Today: 12 May 2026
US Stock Market Today: S&P 500, Nasdaq Slip From Records as Oil Spike Tests Wall Street Rally

US Stock Market Today: S&P 500, Nasdaq Slip From Records as Oil Spike Tests Wall Street Rally

NEW YORK, April 20, 2026, 13:01 EDT

Stocks in the U.S. edged lower Monday, pulling back after last week’s record-setting rally, with oil prices surging and renewed skepticism around a U.S.-Iran ceasefire dampening sentiment. As of 11:41 a.m. ET, the Dow Jones Industrial Average slipped 0.12%, the S&P 500 dropped 0.33%, and the Nasdaq Composite fell 0.55%.

This pullback hits as Wall Street tries to gauge if the rally has legs. Since March 30, the S&P 500 has jumped 12%. On Friday, both the S&P 500 and Nasdaq notched a third consecutive record close. The Nasdaq’s run now stands at 13 sessions—the longest streak since 1992.

Earnings are doing the heavy lifting for this rally. So far, with roughly 10% of S&P 500 names out, close to 90% have topped forecasts. First-quarter profit growth is coming in between 13% and 14%. “The earnings recovery remains intact,” Morgan Stanley’s Michael Wilson and his team said. AP News

Chase Investment Counsel president Peter Tuz pointed to “headlines of the day” out of Iran as the main force behind Monday’s session, though upbeat corporate results curbed losses. “Investors are still looking through the day-to-day moves in the Middle East and turning their focus back to earnings,” said Victoria Fernandez, chief market strategist at Crossmark Global Investments. Reuters

Brent crude surged $4.61, or 5.1%, to hit $94.99 a barrel by 11:26 a.m. ET, while U.S. crude added 5.16%, climbing to $88.18. The jump followed the U.S. seizure of an Iranian cargo ship, with flows through the Strait of Hormuz—once responsible for roughly a fifth of global oil—still crawling.

Tech names were under pressure on the tape. Amazon dropped roughly 1.6%, Meta slipped 2%, weighing on consumer and communications stocks. A bright spot: Marvell tacked on 4% after a report pointed to Google discussing fresh AI chip development with the company.

This week, the focus shifts to whether bottom lines can outpace global turmoil. UnitedHealth is up on Tuesday, Tesla follows Wednesday, then Boeing and Procter & Gamble land later, as investors scour results for any sign that pricier energy and conflict haven’t derailed momentum.

It’s a simple threat—crude prices hold up, and inflation could be next. Michael Mullaney at Boston Partners flagged that the market acted like it had “woken up from a bad dream,” while oil’s rally still threatens to drive Treasury yields up. On Monday, the U.S. 10-year sat at 4.266%. Reuters

One more deadline is on deck: the ceasefire runs out at 8 p.m. Eastern this Tuesday, April 21. Nikos Tzabouras at Tradu flagged the moment, warning that stalled negotiations plus thin ship movement through Hormuz might “push crude even higher” if things fall apart. AP News

At this point, the pullback resembled a breather rather than anything decisive. Updated Bloomberg market data showed both the S&P 500 and Nasdaq holding losses, with the CBOE Volatility Index climbing to 19.42—its highest in a week. Friday’s rally had closed the S&P 500 at a record 7,126.06.

Stock Market Today

  • Wall Street Slides as AI Stocks Falter and Oil Prices Rise Amid Iran Conflict
    May 12, 2026, 5:23 PM EDT. Wall Street paused its record-setting rally as AI stocks declined and oil prices climbed amid tensions with Iran. The S&P 500 dropped 0.2% from its previous high, while the Nasdaq slipped 0.7%. Dow Jones Industrial Average rose slightly by 56 points. Significant losses hit chipmakers: Intel fell 6.8%, Micron Technology 3.6%, trimming strong year-to-date gains. South Korea's Kospi also dropped 2.3%, spooked by potential AI profit redistribution. Brent crude surged 3.4% to $107.77 a barrel due to Strait of Hormuz restrictions from the Iran war. Rising oil costs worsened U.S. inflation, surpassing forecasts, with Treasury yields climbing to 4.45%. Investors anticipate the Federal Reserve may maintain or hike interest rates amid persistent inflation concerns.

Latest article

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

12 May 2026
Tesla shares fell 2.7% to $433.45 after U.S. inflation data pushed Treasury yields higher and Reuters reported long waits and spotty robotaxi service in Texas. The stock swung from a high of $447.56 to a low of $422.39. Tesla’s valuation remains near $1.53 trillion, with a price-to-earnings ratio close to 398. Management cited cautious robotaxi rollout and increased 2026 capital spending above $25 billion.
Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

12 May 2026
Ernexa Therapeutics shares jumped 58.5% to $11.43 Tuesday after renewed investor focus on its preclinical ovarian-cancer therapy ERNA-101, following a May 11 investor event. Trading volume reached about 18.85 million shares. The company reported $8.3 million in cash as of April 30, less than needed for its 12-month plan, and may use an at-the-market stock sale to raise funds.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
Apple Stock Gets Fresh Wall Street Backing Ahead of Earnings as Morgan Stanley Sees $300 Path, Qualcomm Cut
Previous Story

Apple Stock Gets Fresh Wall Street Backing Ahead of Earnings as Morgan Stanley Sees $300 Path, Qualcomm Cut

Pfizer Stock in Focus After FDA Priority Review as Padcev, Obesity Bets Drive Post-COVID Reset
Next Story

Pfizer Stock in Focus After FDA Priority Review as Padcev, Obesity Bets Drive Post-COVID Reset

Go toTop